These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

216 related items for PubMed ID: 1326552

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Quantification of a matrix metalloproteinase-generated aggrecan G1 fragment using monospecific anti-peptide serum.
    Lark MW, Williams H, Hoernner LA, Weidner J, Ayala JM, Harper CF, Christen A, Olszewski J, Konteatis Z, Webber R.
    Biochem J; 1995 Apr 01; 307 ( Pt 1)(Pt 1):245-52. PubMed ID: 7717983
    [Abstract] [Full Text] [Related]

  • 3. Fibroblast and neutrophil collagenases cleave at two sites in the cartilage aggrecan interglobular domain.
    Fosang AJ, Last K, Knäuper V, Neame PJ, Murphy G, Hardingham TE, Tschesche H, Hamilton JA.
    Biochem J; 1993 Oct 01; 295 ( Pt 1)(Pt 1):273-6. PubMed ID: 8216228
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Mutations in the interglobular domain of aggrecan alter matrix metalloproteinase and aggrecanase cleavage patterns. Evidence that matrix metalloproteinase cleavage interferes with aggrecanase activity.
    Mercuri FA, Maciewicz RA, Tart J, Last K, Fosang AJ.
    J Biol Chem; 2000 Oct 20; 275(42):33038-45. PubMed ID: 11032846
    [Abstract] [Full Text] [Related]

  • 7. The interglobular domain of cartilage aggrecan is cleaved by hemorrhagic metalloproteinase HT-d (atrolysin C) at the matrix metalloproteinase and aggrecanase sites.
    Tortorella MD, Pratta MA, Fox JW, Arner EC.
    J Biol Chem; 1998 Mar 06; 273(10):5846-50. PubMed ID: 9488721
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Cleavage of cartilage proteoglycan between G1 and G2 domains by stromelysins.
    Fosang AJ, Neame PJ, Hardingham TE, Murphy G, Hamilton JA.
    J Biol Chem; 1991 Aug 25; 266(24):15579-82. PubMed ID: 1874716
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. MMPs are less efficient than ADAMTS5 in cleaving aggrecan core protein.
    Durigova M, Nagase H, Mort JS, Roughley PJ.
    Matrix Biol; 2011 Mar 25; 30(2):145-53. PubMed ID: 21055468
    [Abstract] [Full Text] [Related]

  • 18. Aggrecan is degraded by matrix metalloproteinases in human arthritis. Evidence that matrix metalloproteinase and aggrecanase activities can be independent.
    Fosang AJ, Last K, Maciewicz RA.
    J Clin Invest; 1996 Nov 15; 98(10):2292-9. PubMed ID: 8941646
    [Abstract] [Full Text] [Related]

  • 19. Analysis of the catabolism of aggrecan in cartilage explants by quantitation of peptides from the three globular domains.
    Sandy JD, Boynton RE, Flannery CR.
    J Biol Chem; 1991 May 05; 266(13):8198-205. PubMed ID: 2022637
    [Abstract] [Full Text] [Related]

  • 20. Cathepsin D cleaves aggrecan at unique sites within the interglobular domain and chondroitin sulfate attachment regions that are also cleaved when cartilage is maintained at acid pH.
    Handley CJ, Mok MT, Ilic MZ, Adcocks C, Buttle DJ, Robinson HC.
    Matrix Biol; 2001 Dec 05; 20(8):543-53. PubMed ID: 11731271
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.